H. Vandenbossche et al., EFFECTS OF ITRACONAZOLE ON CYTOCHROME P-450-DEPENDENT STEROL 14-ALPHA-DEMETHYLATION AND REDUCTION OF 3-KETOSTEROIDS IN CRYPTOCOCCUS-NEOFORMANS, Antimicrobial agents and chemotherapy, 37(10), 1993, pp. 2101-2105
As in other pathogenic fungi, the major sterol synthesized by Cryptoco
ccus neoformans var. neoformans is ergosterol. This yeast also shares
with most pathogenic fungi a susceptibility of its cytochrome P-450-de
pendent ergosterol synthesis to nanomolar concentrations of itraconazo
le. Fifty percent inhibition of ergosterol synthesis was reached after
16 h of growth in the presence of 6.0 +/- 4.7 nM itraconazole, and co
mplete inhibition was reached at approximately 100 nM itraconazole. Th
is inhibition coincided with the accumulation of mainly eburicol and t
he 3-ketosteroid obtusifolione. The radioactivity incorporated from [C
-14]acetate in both compounds represents 64.2% +/- 12.9% of the radioa
ctivity incorporated into the sterols plus squalene extracted from cel
ls incubated in the presence of 10 nM itraconazole. The accumulation o
f obtusifolione as well as eburicol indicates that itraconazole inhibi
ts not only the 14alpha-demethylase but also (directly or indirectly)
the NADPH-dependent 3-ketosteroid reductase, i.e., the enzyme catalyzi
ng the last step in the demethylation at C-4. This latter inhibition o
bviates the synthesis of 4,4-demethylated 14alpha-methylsterols that m
ay function at least partly as surrogates of ergosterol. Eburicol and
obtusifolione are unable to support cell growth, and the 3-ketosteroid
has been shown to disturb membranes. The complete inhibition of ergos
terol synthesis and the accumulation of the 4,4,14-trimethylsterol and
of the 3-ketosteroid together with the absence of sterols, such as 14
alpha-methylfecosterol and lanosterol, which can partly fulfill some f
unctions of ergosterol, are at the origin of the high activity of itra
conazole against C. neoformans. Fifty percent inhibition of growth was
achieved after 16 h of incubation in the presence of 3.2 +/- 2.6 nM i
traconazole.